Diabetes patients have long relied on complex glucagon kits to treat hypoglycemia. Late last summer, Xeris Pharmaceuticals aimed to change that with the first FDA-approved prefilled syringe. Now, its ...

Mounjaro delivered superior A1C reductions versus all comparators in phase 3 SURPASS clinical trials While not indicated for weight loss, Mounjaro led to significantly greater weight reductions versus ...

Insulin is a hormone that helps your body move sugar from the blood into your tissues. When you have diabetes, your body may not make or use insulin the right way, so you may need to take insulin ...

(RTTNews) - The U.S. Food and Drug Administration approved Eli Lilly and Co.'s (LLY) Mounjaro or tirzepatide injection for the treatment of adults with type 2 diabetes. Mounjaro represents the first ...

Danish pharma major Novo Nordisk on Thursday launched in India its once-weekly basal insulin injection, ‘Awiqli’ indicated for treatment of diabetes in adults. The company is introducing Awiqli in two ...

Ecnoglutide, a novel once-weekly injection for type 2 diabetes management, works as well as dulaglutide (a commonly prescribed once-a-week injection to manage diabetes) in lowering blood sugar levels, ...

Novo Nordisk A/S, which faces higher demand for its diabetes and weight-loss drugs than it can meet, signed a long-term agreement with Ypsomed Holding AG for the supply of auto-injectors. Ypsomed is ...

The diabetes and weight loss drug semaglutide (Ozempic) is a popular and powerful treatment option. While the injectable form of Ozempic has gotten plenty of coverage, there’s now the Ozempic pill, an ...

Stevanato is doubling down on Haselmeier’s Axis-D pen injector technology. Having originally licensed the delivery technology in diabetes, Stevanato has now bagged the rights to use it across a wide ...